8 Contradicted by research
Twin studies from Denmark demonstrate that identical twins with differing lifestyle habits (such as smoking, obesity, and sun exposure) exhibit substantially different physical aging rates.
"There are actually twin studies mostly from Denmark. Identical twins: one that goes and smokes and gets obese and goes in the sun, and they are much older-looking than their identical twin, essentially proving that the DNA is not the reason you age." (said at 0:35:34)
The Danish Longitudinal Study of Aging Twins did evaluate environmental determinants of perceived facial age and survival, but the speaker's specific statements invert key findings and misrepresent the genetic conclusions. First, in elderly Danish twins (age 70+), it was low BMI—not obesity—that was significantly associated with higher perceived facial age (older appearance), because facial volume loss accentuates wrinkles. Second, while smoking and sun exposure were associated with looking older, the study found that non-genetic/environmental factors accounted for approximately 40% of the variance in perceived age, with the remaining ~60% attributable to genetic factors. Thus, the evidence contradicts the claim that obesity makes twins look older in this cohort, as well as the assertion that these studies prove DNA is not why we age.
The global human population is projected to begin a steep decline by the year 2050.
"cuz by 2050 we're going to start going in a bad decline and earlier in many Western countries." (said at 0:57:02)
Major global demographic forecasting models do not project the global human population to begin declining by 2050. According to reference projections published in The Lancet (GBD/IHME), the global population is projected to continue growing until peaking in 2064 at approximately 9.73 billion before declining to 8.79 billion by 2100 (and the United Nations projects peak population even later, in the 2080s). While fertility rates are projected to fall below the replacement level (TFR < 2.1) in 151 countries by 2050, and several individual countries (such as Japan, Spain, and Italy) are projected to experience population decline earlier, the aggregate global population is not projected to start declining by 2050.
Fasting raises NAD levels in both humans and yeast.
"And so what we found was that when we fast the yeast or we fast a human, NAD levels go up again. So fasting raises NAD and makes the sirtuins young again, essentially." (said at 1:18:56)
The speaker's assertion that fasting/calorie restriction raises NAD+ levels in yeast is directly contradicted by published mechanistic studies from yeast longevity research (including work from the speaker's own field). In Saccharomyces cerevisiae, calorie restriction extends lifespan not by increasing NAD+ levels, but by upregulating PNC1 to deplete nicotinamide (an endogenous inhibitor of Sir2), while nuclear NAD+ levels actually decrease or remain unchanged (PMID: 14605207, PMID: 12736687). In humans, robust clinical trial evidence demonstrating that fasting raises tissue or whole-blood NAD+ levels is lacking.
Human clinical trials have demonstrated that sirtuin activation via NMN lowers body weight, reduces inflammation, and improves cholesterol levels.
"And we believe, and we have some evidence now in human clinical trials, that the sirtuins are imparting health benefits, reestablishing the epigenome, lowering body weight, improving inflammation, and even changing cholesterol levels in a positive way in humans." (said at 1:20:26)
The speaker claimed that human clinical trials show NMN/sirtuin activation lowers body weight, improves inflammation, and positively alters cholesterol levels. However, systematic reviews and meta-analyses of randomized controlled trials examining oral NMN supplementation in humans have found no statistically significant effects on body weight, BMI, lipid/cholesterol profiles, or glycemic parameters.
- contradicts: Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A System… (Current diabetes reports 2024) · cited 8x in the literature
"The random-effects meta-analyses indicated no significant benefit of NMN on fasting glucose, fasting insulin, glycated hemoglobin, homeostatic model assessment for insulin resistance and lipid profile. Based on the small number of RCTs involving mainly relatively healthy adults, short-term supplementation of NMN of 250-2000 mg/d did not show significantly positive impacts on glucose control and lipid profile." (abstract, results and conclusions, passage verified)
pubmedfull study (doi) - contradicts: NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review… (Ageing research reviews 2026) · cited 7x in the literature
"In humans, oral NR and NMN consistently demonstrated biochemical target engagement (circulating (plasma/whole blood) or cellular (e.g., PBMC) NAD-related metabolites) and were generally well tolerated over weeks to months; however, effects on functional, metabolic, vascular, and other healthspan-relevant outcomes were heterogeneous and often null or endpoint-specific." (abstract, results and conclusions, passage verified)
pubmedfull study (doi) - contradicts: Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation… (Nutrients 2026)
"No significant effects were observed on body weight, BMI, fasting glucose, HbA1c, lipid profiles, or systolic blood pressure." (abstract, results, passage verified)
pubmedfull study (doi)
In cellular biochemistry, two NMN molecules are put together to form NAD inside a cell.
"NMN is directly converted into NAD. You put two NMNs together, you get NAD in cell. We know this for a fact." (said at 1:20:01)
The speaker's claim that NAD is formed by putting two NMN molecules together is biochemically incorrect. Inside cells, nicotinamide adenine dinucleotide (NAD+) is synthesized by the enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT), which conjugates one molecule of NMN with one molecule of ATP (adenosine triphosphate) to generate NAD+ and inorganic pyrophosphate (PPi). NAD is a dinucleotide composed of a nicotinamide nucleotide linked to an adenine nucleotide, not two nicotinamide mononucleotides joined together.
Spermidine was first discovered and crystallized in human semen by Antoni van Leeuwenhoek.
"Well, that's how it was discovered. It was crystallized by, I believe, Antoni van Leeuwenhoek, the one of the first microscopists and microbiologists." (said at 1:51:51)
Antoni van Leeuwenhoek did not discover or crystallize spermidine; in 1678, he observed and described crystals in human semen that were later identified as spermine (specifically spermine phosphate). Spermidine was isolated and characterized much later, in the 1920s by Dudley, Rosenheim, and colleagues. While both spermine and spermidine are related polyamines, the historical crystallization in semen by Leeuwenhoek is specifically the discovery of spermine.
Shading green tea plants prior to harvesting increases their chlorophyll and polyphenol content.
"the growers of those plants in Japan, typically, they shade the plants before they harvest. Shading the plants stresses them out. Plants need light. So they don't just make more chlorophyll, which produces the deep green color in the tea, but the polyphenols are super high." (said at 1:31:16)
The speaker bundles two assertions: that shading tea plants prior to harvest increases chlorophyll (accurate) and that it increases polyphenol content (contradicted). In tea cultivation (such as the production of tencha/matcha and gyokuro in Japan), pre-harvest shading stimulates chlorophyll and L-theanine accumulation while down-regulating flavonoid biosynthesis pathways driven by light and UV radiation. Consequently, shading significantly decreases major catechins and total polyphenol content compared to sun-grown tea leaves, reducing bitterness and astringency.
- contradicts: Biosynthesis of catechin components is differentially regulated in dark-treated tea (… (Plant physiology and biochemistry : PPB 2014) · cited 62x in the literature
"The vanillin assay showed that the dark-treated plants contained lower levels of total catechins than those grown under normal conditions." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Metabolomic analysis using ultra-performance liquid chromatography-quadrupole-time of flig… (PloS one 2014) · cited 141x in the literature
"Most flavonoid metabolites (mainly flavan-3-ols, flavonols and their glycosides) decreased significantly in the shading treatments, while the contents of chlorophyll, β-carotene, neoxanthin and free amino acids, caffeine, benzoic acid derivatives and phenylpropanoids increased." (abstract, results)
pubmedfull study (doi) - contradicts: Metabolite profiling and transcriptomic analyses reveal an essential role of UVR8-mediated… (BMC plant biology 2018) · cited 129x in the literature
"While shading enhanced chlorophyll accumulation, major catechins, including C, EC, GC and EGC, decreased significantly in tea buds throughout the whole shading period. The reduction of catechins and flavonols were consistent with the simultaneous down-regulation of biosynthetic genes and TFs associated with flavonoid biosynthesis." (abstract, results, passage verified)
pubmedfull study (doi)
Macular degeneration is the largest cause of blindness besides glaucoma.
"If they work, then we go on to macular degeneration, which is the largest cause of blindness besides glaucoma." (said at 2:08:27)
Global epidemiological data from the Global Burden of Disease (GBD) Study and the World Health Organization show that cataract is by far the leading cause of blindness worldwide, not glaucoma. In 2020, among adults aged 50 and older, the leading global causes of blindness were cataract (15.2 million cases), glaucoma (3.6 million cases), undercorrected refractive error (2.3 million cases), and age-related macular degeneration (1.8 million cases). In high-income countries, age-related macular degeneration is often the leading cause of irreversible blindness (surpassing glaucoma), rather than second to it.
- contradicts: Causes of vision loss worldwide, 1990-2010: a systematic analysis. (The Lancet. Global health 2013) · cited 1887x in the literature
"Leading causes worldwide in 1990 and 2010 for blindness were cataract (39% and 33%, respectively), uncorrected refractive error (20% and 21%), and macular degeneration (5% and 7%)..." (abstract, results)
pubmedfull study (doi) - contradicts: Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence… (The Lancet. Global health 2021) · cited 3152x in the literature
"The leading global causes of blindness in those aged 50 years and older in 2020 were cataract (15·2 million cases [9% IU 12·7-18·0]), followed by glaucoma (3·6 million cases [2·8-4·4]), undercorrected refractive error (2·3 million cases [1·8-2·8]), age-related macular degeneration (1·8 million cases [1·3-2·4]), and diabetic retinopathy (0·86 million cases [0·59-1·23])." (abstract, results)
pubmedfull study (doi)
11 Overstated
Smoking, getting an X-ray, consuming ultra-processed foods, excessive drinking, and frequent flying accelerate the aging process.
"So, you can accelerate aging by smoking, getting an X-ray, ultra-processed foods, excessive drinking, flying a lot." (said at 0:00:40)
The speaker bundles established lifestyle risk factors with minor radiation exposures. Observational and epigenetic clock studies consistently confirm that cigarette smoking, heavy alcohol intake, and diets high in ultra-processed or fast foods accelerate biological and epigenetic aging (e.g., DunedinPACE, GrimAge, leukocyte telomere attrition). However, claiming that routine diagnostic X-rays or commercial air travel accelerate biological aging overstates the evidence: standard medical X-rays deliver negligible doses of ionizing radiation, and while high-dose radiation or spaceflight causes cellular damage and senescence, there is no direct evidence that routine clinical X-rays or standard airline travel meaningfully accelerate systemic biological aging in humans.
- partial: Processed Meat, but Not Unprocessed Red Meat, Is Inversely Associated with Leukocyte Telom… (The Journal of nutrition 2016) · cited 43x in the literature
"Consumption of processed meat was negatively associated with LTL after adjustment for age, sex, site, education, smoking, alcohol use, physical activity, and other dietary factors." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Suboptimal dietary patterns are associated with accelerated biological aging in young adul… (Clinical nutrition (Edinburgh, Scotland) 2025) · cited 29x in the literature
"Diets high in fast food, processed red meat, and sugar-sweetened beverages and low in fruits and vegetables are associated with accelerated biological aging in young adulthood." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Substance use and epigenetic age acceleration: Associations with alcohol, tobacco, illicit… (Drug and alcohol dependence 2026)
"Clinically significant alcohol use (β=0.177, p = 2.111e-08) was positively associated with AgeAccelGrim2 but not DunedinPACE. The categorical measure of cigarette smoking was positively associated with both AgeAccelGrim2 and DunedinPACE at all levels of smoking" (abstract, results)
pubmedfull study (doi)
The underlying universal biological process of aging causes approximately 150,000 to 200,000 human deaths each day globally.
"what's really causing about 150 to 200,000 people every day to die, is the underlying universal process we call aging." (said at 0:06:20)
The speaker claims that biological aging causes approximately 150,000 to 200,000 deaths per day worldwide. According to global demographic and epidemiological data (such as the Global Burden of Disease Study 2021, PMID: 38484753), approximately 150,000 to 180,000 people die each day globally from *all causes combined* (roughly 55-65 million deaths per year, or ~131 million across 2020-2021). Of these total deaths, roughly two-thirds (~100,000 to 110,000 per day globally, and up to ~90% in high-income countries) are attributable to age-related chronic diseases (e.g., cardiovascular diseases, cancers, neurodegenerative disorders). Thus, the speaker conflates total global daily all-cause mortality with the subset of deaths driven by age-related biological decline/diseases.
Oral administration of a liquid chemical compound can rejuvenate mouse tissues, such as skin and ears, within four weeks.
"The new technology is something you can swallow in a mouse and rejuvenate them in 4 weeks. It's normal for my students to say, "Oh yeah, we just rejuvenated the ear. We just rejuvenated the skin. Uh we just cured ALS, motor neuron disease in these animals."" (said at 0:15:09)
The speaker's claims conflate preliminary in vitro cell-culture findings and unverified laboratory observations with established in vivo therapeutic efficacy. In 2023, David Sinclair's laboratory published an in vitro study identifying chemical cocktails that reversed transcriptomic aging markers in cultured human cells in less than a week (PMID: 37437248). However, robust peer-reviewed evidence demonstrating that an orally administered ('swallowed') chemical cocktail safely rejuvenates mouse skin, ears, or other tissues within 4 weeks—or cures amyotrophic lateral sclerosis (ALS) / motor neuron disease in animal models—has not been established in published literature.
- partial: Chemically induced reprogramming to reverse cellular aging. (Aging 2023) · cited 134x in the literature
"We identify six chemical cocktails, which, in less than a week and without compromising cellular identity, restore a youthful genome-wide transcript profile and reverse transcriptomic age. Thus, rejuvenation by age reversal can be achieved, not only by genetic, but also chemical means." (abstract, results, passage verified)
pubmedfull study (doi) - context: Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming. (Nature aging 2024) · cited 57x in the literature
"Here we discuss the current state of epigenetic rejuvenation strategies via partial reprogramming in both mouse and human models. For each classical reprogramming factor, we provide a brief description of its contribution to reprogramming and discuss additional factors or chemical strategies." (abstract, results, passage verified)
pubmedfull study (doi)
David Sinclair's group has successfully performed age reversal interventions in non-human primates (monkeys).
"But I do want to remind you and everyone listening and watching that we're beyond mice now for age reversal. We've done this in monkeys, monkeys that are physically and almost genetically identical to us." (said at 0:46:35)
The claim that age reversal has been achieved in monkeys overstates the published scientific record. Published peer-reviewed research by David Sinclair's laboratory and collaborators has demonstrated partial epigenetic reprogramming and vision restoration using Yamanaka factors (Oct4, Sox2, Klf4 / OSK) in mice (e.g., optic nerve injury, glaucoma, and aged mice models) and in vitro human cells. While preliminary non-human primate work (involving an experimental laser-induced optic neuropathy model) has been presented in conference abstracts by affiliated biotechnology companies, there is no peer-reviewed evidence establishing generalized or systemic 'age reversal' in monkeys.
- partial: Sustained Vision Recovery by OSK Gene Therapy in a Mouse Model of Glaucoma. (Cellular reprogramming 2023) · cited 31x in the literature
"Previously, we developed a novel epigenetic rejuvenation therapy, based on the expression of the three transcription factors Oct4 , Sox2 , and Klf4 (OSK), which safely rejuvenates RGCs without altering cell identity in glaucomatous and old mice after 1 month of treatment." (abstract, background, passage verified)
pubmedfull study (doi) - context: Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming. (Nature aging 2024) · cited 57x in the literature
"Here we discuss the current state of epigenetic rejuvenation strategies via partial reprogramming in both mouse and human models." (abstract, results, passage verified)
pubmedfull study (doi)
A person's perceived visual age is a strong representation of the biological age and health of their internal organs.
"What is true that's often not comfortable is how old you look is a very good representation of how old you are in your organs as well." (said at 0:35:45)
While epidemiological studies have shown modest associations between perceived facial age, certain health phenotypes, and all-cause mortality, describing facial appearance as a 'very good representation' of internal biological and organ age is overstated. Studies evaluating molecular markers of biological aging (such as blood DNA methylation and epigenetic clocks) demonstrate that facial aging does not correlate well with these systemic biological age indicators.
Reversing the biological age of the brain in mouse models of Alzheimer's disease causes the disease and dementia symptoms to resolve.
"and we can do that, we can put in the human genes for Alzheimer's into a mouse, it has dementia—when we reverse the age of the brain of that animal, we're not treating the disease, we're treating aging. The disease goes away." (said at 0:42:35)
Preclinical studies demonstrate that partial in vivo cellular reprogramming via controlled/cyclical expression of Yamanaka factors can partially restore epigenetic age markers, reduce tau pathology, and ameliorate cognitive and synaptic deficits in transgenic Alzheimer's disease mouse models (such as 5xFAD and Tau-P301S). However, asserting that 'the disease goes away' is an overstatement; the interventions mitigate or rescue specific pathological and behavioral features in rodent models rather than completely eradicating the disease, and these preclinical findings have not been demonstrated in humans.
- partial: Expansion of the neocortex and protection from neurodegeneration by in vivo transient… (Cell stem cell 2024) · cited 22x in the literature
"Additionally, controlled YF induction is tolerated by principal neurons in the adult dorsal hippocampus and prevented the development of several hallmarks of Alzheimer's disease, including cognitive decline and altered molecular signatures, in the 5xFAD mouse model." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Partial reprogramming by cyclical overexpression of Yamanaka factors improves pathological… (Progress in neurobiology 2025) · cited 11x in the literature
"The results of this study show a significant improvement in key pathological features of tauopathies in the hippocampus, including reversed tauopathy, alleviated reactive astrogliosis, age-related reduction of the H3K9me3 epigenetic marker, along with improved spatial memory, which has been described as deteriorated in this model." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Targeted neuronal reprogramming rescues memory and neural synchrony in Alzheimer's disease… (Molecular biomedicine 2026)
"This intervention led to a sex-dependent improvement in cognitive and emotional behaviors in P301S mice, accompanied by a reduction in Tau pathology and partial restoration of epigenetic aging markers." (abstract, results, passage verified)
pubmedfull study (doi)
By age 50, humans have approximately half the levels of NAD compared to when they were young.
"As we get older, by the time you're 50, about my age, you have half the levels of this NAD molecule. My body is making less NAD and it's also destroying the NAD faster than when I was 20." (said at 1:18:45)
While preclinical animal models consistently demonstrate age-associated reductions in tissue NAD+ levels, evidence for an approximate 50% decline in humans by age 50 is substantially overstated and inconsistent across tissues. Clinical reviews highlight that robust human tissue data remain sparse and cannot simply be extrapolated from rodents. Furthermore, large human cohort studies using validated mass spectrometry methods have found that human blood NAD+ levels remain stable across age groups.
Chaperone-mediated autophagy is deeply activated after 2.5 to 3 days of fasting.
"But the true, real, deep cleansing of old proteins and damaged proteins happens after 2 and 1/2 to 3 days. And it's called chaperone-mediated autophagy." (said at 1:23:55)
The speaker's general premise that chaperone-mediated autophagy (CMA) selectively degrades cytosolic proteins containing specific pentapeptide motifs and is activated during prolonged starvation/nutrient deprivation (in contrast to initial non-selective macroautophagy) is mechanistically correct based on preclinical and cellular models. However, assigning a precise human clinical timeline of '2.5 to 3 days' (60-72 hours) as the threshold for 'deeply activated' CMA overstates the human evidence. Most mechanistic data on CMA kinetics derive from rodent and in vitro cell culture models (e.g., rodent liver starvation models typically show activation after 10-24 hours of fasting). In vivo human dynamic measurement of CMA during prolonged fasting has not been directly quantified with fixed multi-day thresholds.
Metformin reduces muscle hypertrophy in weightlifters by approximately 5% compared to those who do not take it, by impairing mitochondrial energy production.
"Metformin has been shown to make athletes and bodybuilders and people who go to the gym, weightlifters, um do less repetitions and as a result, their muscles are about 5% less compared to those that don't take metformin in size. I don't think it's molecular. I think it's because you feel a little bit weaker with metformin because it's actually interfering with your body's ability to make energy through mitochondria." (said at 1:42:02)
The claim is overstated. Randomized controlled trial evidence (the MASTERS trial, PMID 31557380) demonstrated that metformin blunts muscle hypertrophy (lean body mass and thigh muscle area gains) in response to 14 weeks of progressive resistance exercise training. However, this was demonstrated in healthy older adults (aged 65 and older), not in young athletes, bodybuilders, or trained weightlifters. Furthermore, the trial found molecular alterations (increased AMPK signaling and altered mTORC1 signaling/transcriptomic responses) rather than evidence that individuals performed fewer repetitions due to perceived weakness.
Researchers have successfully cured total blindness in monkeys, restoring their sight within six weeks.
"The fact that we are aiming and already do cure blindness in monkeys. Like pure blindness. This isn't just, oh, I can't see a little bit. These are completely blind animals. Um and that they can see again in a matter of 6 weeks." (said at 2:00:49)
The speaker significantly exaggerates preclinical research on epigenetic reprogramming (OSK gene therapy). Published peer-reviewed research by this group demonstrated partial reversal of vision impairment in mouse models of glaucoma, optic nerve crush, and normal aging, not complete blindness in non-human primates. While conference abstracts and company announcements reported preliminary functional improvements (e.g., in pattern electroretinograms) in non-human primate models of laser-induced optic neuropathy, peer-reviewed evidence curing total blindness in monkeys within six weeks does not exist.
- context: Reprogramming to recover youthful epigenetic information and restore vision. (Nature 2020) · cited 852x in the literature
"Using the eye as a model CNS tissue, here we show that ectopic expression of Oct4 (also known as Pou5f1), Sox2 and Klf4 genes (OSK) in mouse retinal ganglion cells restores youthful DNA methylation patterns and transcriptomes, promotes axon regeneration after injury, and reverses vision loss in a mouse model of glaucoma and in aged mice." (abstract, results, passage verified)
pubmedfull study (doi) - context: Sustained Vision Recovery by OSK Gene Therapy in a Mouse Model of Glaucoma. (Cellular reprogramming 2023) · cited 31x in the literature
"Previously, we developed a novel epigenetic rejuvenation therapy, based on the expression of the three transcription factors Oct4 , Sox2 , and Klf4 (OSK), which safely rejuvenates RGCs without altering cell identity in glaucomatous and old mice after 1 month of treatment." (abstract, background, passage verified)
pubmedfull study (doi) - context: Epigenetic reprogramming for ocular aging and disease: Mechanisms, biomarkers, and the roa… (Progress in retinal and eye research 2026) · cited 5x in the literature
"Compelling preclinical studies have validated this approach by demonstrating vision restoration in models of optic neuropathy through the rejuvenation of damaged and aged neurons." (abstract, results, passage verified)
pubmedfull study (doi)
Stroke of the eye (non-arteritic anterior ischemic optic neuropathy) is becoming more prevalent due to Ozempic and other GLP-1 weight loss drugs, affecting approximately 30,000 people annually in the United States.
"There's also a stroke in the eye, which is becoming more prevalent in the world because of Ozempic and other weight loss drugs, and people go blind overnight, and there's nothing that you can do for those patients... It's pretty common these days, about 30,000 people each year in the US alone." (said at 2:07:36)
Observational studies and meta-analyses have observed a statistical association between semaglutide (Ozempic/Wegovy) and non-arteritic anterior ischemic optic neuropathy (NAION, often described informally as a stroke of the optic nerve), with relative risk estimates around 2.4-fold to 2.5-fold compared with other antidiabetic or weight loss medications. However, the claim is heavily overstated: NAION remains an uncommon-to-rare event rather than 'pretty common', absolute excess risk is low (around 3 to 4 additional cases per 10,000 patients over 18 months), and major neuro-ophthalmology consensus panels (NANOS/AAO) emphasize that causal proof is not established. Furthermore, the figure of 30,000 cases annually in the US attributable to or occurring alongside GLP-1s is unsupported; total annual NAION cases from all causes across the entire US population have historically been estimated at only 6,000 to 10,000 cases per year.
- partial: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide… (JAMA ophthalmology 2024) · cited 283x in the literature
"This study's findings suggest an association between semaglutide and NAION. As this was an observational study, future study is required to assess causality." (abstract, conclusions, passage verified)
pubmedfull study (doi) - partial: Glucagon-like Peptide-1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic… (Neurology 2026) · cited 3x in the literature
"Semaglutide use was associated with a high probability of increased risk of NAION compared with non-GLP-1RA use (RR: 2.52, 95% CrI [1.56, 4.72], I 2 : 57.8%, P(RR > 1): 99.9%)... The incidence of NAION across 1,108,542 semaglutide users was 118 cases per 100,000 (95% CrI [32, 451], I 2 : 98.8%, P(incidence >0.00001): 100%)." (abstract, results)
pubmedfull study (doi) - partial: Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Non-Arteritic Anterior Ischemic … (Ophthalmology 2026) · cited 2x in the literature
"Although many report a small possible increased risk of NAION in patients taking GLP-1 RAs such as semaglutide, some studies report no correlation, and the overall magnitude of the risk of NAION remains low." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Glucagon-Like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy : A Targe… (Annals of internal medicine 2026)
"The 18-month risk for ION was 8.5 versus 5.5 per 10 000 among GLP-1RA users versus SGLT2i users (RD, 3.0 [95% CI, 0.4 to 5.7]) and 7.8 versus 4.2 per 10 000 among GLP-1RA users versus DPP4i users (RD, 3.6 [CI, 1.1 to 6.1])." (abstract, results)
pubmedfull study (doi)
43 Supported by research
Blasting your eardrums with loud music accelerates the aging of ear hair cells.
"Even going to a rock concert and blasting your eardrums because your ear hair cells are getting older faster." (said at 0:00:46)
The claim that loud noise overexposure (such as loud music) accelerates cochlear hair cell aging is supported by preclinical and transcriptomic evidence. Animal models demonstrate that acoustic trauma triggers cellular senescence pathways, oxidative stress, and inflammatory cascades (such as the senescence-associated secretory phenotype), which accelerate subsequent age-related hair cell degeneration and synaptopathy. However, because direct cellular and histological verification comes from animal models rather than in vivo human histology, the certainty is graded as very low.
- supports: Bioinformatics Re-analysis of murine transcriptomic datasets identifies SASP and MAPK/NF-&… (Hearing research 2026)
"Our integrative analysis implicated inflammation, cell cycle arrest, aberrant extracellular matrix remodeling, and lipid peroxidation-associated atherosclerosis as potential mechanisms through which noise exposure accelerates cochlear aging." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Cochlear aging after synaptopathic noise: age-noise interactions in hair cell loss and axo… (Hearing research 2026)
"Inner hair cells showed no losses at 1 month, whereas, at later ages, noise-exposed ears showed enhanced degeneration in the extreme base." (abstract, results, passage verified)
pubmedfull study (doi)
Introducing three specific genes into the optic nerve and activating them for 6 to 8 weeks resets the cellular age of the nerves by approximately 75%.
"what we're doing is we're introducing a set of three genes into this optic nerve at the back of the eye and turning them on for 6 to 8 weeks. And those three genes are what we now know reset safely apparently safely reset the age of cells including nerves by about 75% and then stop." (said at 0:11:30)
The speaker accurately summarizes preclinical research from David Sinclair's laboratory (Lu et al., Nature 2020), which demonstrated that delivering three Yamanaka transcription factors (Oct4, Sox2, and Klf4; OSK) into mouse retinal ganglion cells restores youthful DNA methylation patterns (epigenetic clock age reduction) and promotes axon regeneration and vision recovery in mouse models of glaucoma and normal aging without inducing pluripotency-associated toxicity or tumorigenesis. Because this body of evidence is currently confined to animal models (mice) and in vitro systems, the GRADE certainty is very low.
- supports: Reprogramming to recover youthful epigenetic information and restore vision. (Nature 2020) · cited 852x in the literature
"Using the eye as a model CNS tissue, here we show that ectopic expression of Oct4 (also known as Pou5f1), Sox2 and Klf4 genes (OSK) in mouse retinal ganglion cells restores youthful DNA methylation patterns and transcriptomes, promotes axon regeneration after injury, and reverses vision loss in a mouse model of glaucoma and in aged mice." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Sustained Vision Recovery by OSK Gene Therapy in a Mouse Model of Glaucoma. (Cellular reprogramming 2023) · cited 31x in the literature
"Previously, we developed a novel epigenetic rejuvenation therapy, based on the expression of the three transcription factors Oct4 , Sox2 , and Klf4 (OSK), which safely rejuvenates RGCs without altering cell identity in glaucomatous and old mice after 1 month of treatment." (abstract, results, passage verified)
pubmedfull study (doi)
Systemically injecting three age-reversal genes into the veins of old mice (equivalent to 80 to 85 human years) produced an additional 100% extension of remaining lifespan.
"Instead of putting the three reversal genes into the eye, they injected into the vein of the mouse, the old mice. Uh and turned it on in these really old mice. These mice would be the equivalent of about 80 to 85 years. So, they're really old mice. They're really frail. And just any any extension in their lifespan and health would be bet would be a great thing. And they got an additional 100% lifespan extension. Additional." (said at 0:12:25)
A 2024 study (Macip et al.) evaluated systemic delivery of adeno-associated viruses encoding three Yamanaka factors (Oct4, Sox2, and Klf4; OSK) into extremely aged 124-week-old mice (approximately equivalent to 80–85 human years). The authors found that inducible OSK gene therapy increased median remaining lifespan by 109% compared to controls and significantly improved frailty parameters. As this evidence is derived entirely from animal models, the GRADE certainty is very low.
The DNA chemical inside every human cell is approximately 6 feet long.
"DNA, the information of life that we get from our parents is a chemical that's about 6 ft long in every cell." (said at 0:23:20)
The total linear length of nuclear DNA in a diploid human cell is approximately 2 meters (about 6 to 6.5 feet) when fully extended and uncoiled. This standard biological fact is widely established across genome biology and structural biology literature describing how chromatin condenses this length into a microscopic cell nucleus.
The human genome contains about 20,000 genes, of which about 15,000 are turned on.
"There are about 20,000 genes, about 15,000 are turned on, but a different set gets turned on in large part to make a nerve cell compared to a liver cell and a skin cell." (said at 0:24:35)
Current human genome annotations (such as GENCODE, Ensembl, and RefSeq) define approximately 19,000–20,000 protein-coding genes. Comprehensive transcriptomic and proteomic atlases across human tissues (such as the Human Protein Atlas) confirm that typical tissues express roughly 11,000 to 15,000 genes, with tissue-specific and cell-type-specific expression profiles determining distinct cellular identities (such as neurons versus hepatocytes).
Every cell in the human body experiences at least one broken chromosome every day, amounting to approximately 20 trillion chromosome breakage events daily across the body.
"every one of your cells has at least one broken chromosome every day—that's 20 trillion of these events every day in your body—over time, tick tick tick, you get the aging process, we believe." (said at 0:29:15)
The speaker's statement that every cell experiences at least one broken chromosome (DNA double-strand break, or DSB) per day—totaling approximately 20 trillion breakage events daily across the ~30 trillion cells of the human body—is consistent with established estimates in DNA damage and repair biology. Endogenous metabolic processes, replication stress, and oxidative stress routinely produce an estimated 10 to 50 double-strand breaks per human cell per day (alongside tens of thousands of single-strand lesions). Cells continuously utilize non-homologous end joining (NHEJ) and homologous recombination (HR) to repair these breaks, but cumulative repair inefficiencies contribute to genomic and epigenomic alterations associated with aging.
- supports: The Double Face of Base Excision Repair: Preventing and Triggering Double-Strand Breaks. (BioEssays : news and reviews in molecular, cellular and developmental biology 2026) · cited 2x in the literature
"Recent evidence confirms that the base excision repair (BER) machinery not only acts to restore an intact double DNA helix by replacing oxidized bases, but under some circumstances, BER goes awry, generating double-strand breaks and provoking chromosome fragmentation." (abstract, results, passage verified)
pubmedfull study (doi) - supports: The relationship between DNA damage and repair and the occurrence and development of disea… (Frontiers in genetics 2026)
"In eukaryotes, there are four main types of DNA repair: nucleotide excision repair (NER), base excision repair (BER), mismatch repair (MMR), and double-strand break repair (DSB repair)... while DSB repair includes two mechanisms: non-homologous end joining (NHEJ) and homologous recombination (HR)." (abstract, results)
pubmedfull study (doi)
Inducing non-mutagenic DNA double-strand breaks in mice (ICE mice) accelerates physiological aging and the onset of aging-related diseases by approximately 50%.
"So we could take a mouse and for 3 weeks we turned on the slime mold-cutting protein... But we set in motion a cascade of accelerated aging events that about 10 months later, they were super gray and super old and had all the diseases of aging 50% faster than their twins that we didn't treat." (said at 0:31:43)
The speaker accurately describes the experimental design and findings of their 2023 Cell study (Yang et al., PMID 36638792). In this study, the authors developed the 'ICE' (inducible changes to the epigenome) mouse model using a cut-and-repair endonuclease (I-PpoI, derived from the slime mold Physarum polycephalum) turned on for 3 weeks to induce non-mutagenic DNA double-strand breaks. Following repair, the treated mice exhibited accelerated molecular, cognitive, and physiological signs of aging compared to untreated littermate controls. Because the supporting evidence comes strictly from an animal study, the certainty is graded as very low.
- supports: Loss of epigenetic information as a cause of mammalian aging. (Cell 2023) · cited 637x in the literature
"Using a system called "ICE" (inducible changes to the epigenome), we find that the act of faithful DNA repair advances aging at physiological, cognitive, and molecular levels, including erosion of the epigenetic landscape, cellular exdifferentiation, senescence, and advancement of the DNA methylation clock, which can be reversed by OSK-mediated rejuvenation." (abstract, passage verified)
pubmedfull study (doi)
Epigenetics and lifestyle factors account for 80% to 90% of a person's rate of aging rather than inherited DNA.
"It turns out your DNA is not your destiny. It's the epigenome. So how you live your life is really 80 to 90% of your rate of aging." (said at 0:35:15)
Large-scale twin and pedigree studies consistently indicate that inherited genetic variation accounts for only approximately 10% to 25% of the variation in human lifespan and aging, meaning that environmental, epigenetic, and lifestyle factors account for the remaining 75% to 90% or more. For example, a landmark study analyzing pedigrees of over 400 million individuals found that true heritability of human longevity is well below 10% after accounting for assortative mating, leaving greater than 90% attributable to non-inherited influences.
Consuming more than one alcoholic drink per day is detrimental to health.
"Avoid excessive drinking. We now know that even more than one glass a day of alcohol is bad." (said at 0:36:40)
Large-scale pooled prospective cohort studies and global meta-analyses support the statement that consuming more than one alcoholic drink per day is detrimental to health. A landmark 2018 Lancet analysis of nearly 600,000 current drinkers (Wood et al.) established that the threshold for lowest all-cause mortality risk is approximately 100 g of alcohol per week (equivalent to about one standard drink per day or ~12.5 UK units/week). Intakes exceeding 100 g/week were associated with higher risks of stroke, heart failure, fatal hypertensive disease, and reduced life expectancy. Furthermore, the 2016 Global Burden of Disease systematic analysis found that the level of consumption minimizing total health loss across 23 disease outcomes is zero.
- supports: Risk thresholds for alcohol consumption: combined analysis of individual-participant data … (Lancet (London, England) 2018) · cited 1171x in the literature
"In current drinkers of alcohol in high-income countries, the threshold for lowest risk of all-cause mortality was about 100 g/week. For cardiovascular disease subtypes other than myocardial infarction, there were no clear risk thresholds below which lower alcohol consumption stopped being associated with lower disease risk." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis… (Lancet (London, England) 2018) · cited 3630x in the literature
"We found that the risk of all-cause mortality, and of cancers specifically, rises with increasing levels of consumption, and the level of consumption that minimises health loss is zero." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Having a strong human bond, a reliable partner, or a pet slows biological aging and is associated with increased longevity compared to being lonely.
"If you don't have a reliable partner, have a pet. Because the human bond is something that is shown to slow aging and associates with people who live longer than others that are lonely." (said at 0:37:15)
Substantial epidemiological evidence and meta-analyses confirm that strong social bonds and partnerships are associated with significantly increased longevity and reduced mortality risk compared to loneliness or social isolation. A landmark meta-analysis of 148 studies (308,849 participants) by Holt-Lunstad et al. demonstrated a 50% increased likelihood of survival for individuals with stronger social relationships. Furthermore, recent cohort studies using biological aging biomarkers (such as GrimAge DNA methylation clocks) have demonstrated that loneliness is significantly associated with accelerated biological/epigenetic aging. Systematic reviews on pet ownership also show beneficial associations with cardiovascular health and survival outcomes.
- supports: Social relationships and mortality risk: a meta-analytic review. (PLoS medicine 2010) · cited 7308x in the literature
"Across 148 studies (308,849 participants), the random effects weighted average effect size was OR = 1.50 (95% CI 1.42 to 1.59), indicating a 50% increased likelihood of survival for participants with stronger social relationships." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Association between pet ownership and cardiovascular risks and mortality: a systematic rev… (Journal of cardiovascular medicine (Hagerstown, Md.) 2020) · cited 18x in the literature
"Higher survival rate was observed in the pet owners group after pooling nonadjusted and adjusted hazard ratios for cardiovascular mortality at 0.73 [95% confidence interval (CI) 0.62-0.86] and 0.81 (0.68-0.97), respectively." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Associations Between Loneliness, Epigenetic Aging, and Multimorbidity Through Older Adulth… (The journals of gerontology. Series B, Psychological sciences and social sciences 2024) · cited 18x in the literature
"Baseline loneliness was associated with greater EAA in the GrimAge measure net of demographic and behavioral covariates (β = 0.07, p = .003)." (abstract, results)
pubmedfull study (doi)
The bristlecone pine is the longest-lived tree species in the world and can live for thousands of years.
"the bristlecone pine. What's that? It's the longest-lived tree in the world. It can live many thousands of years." (said at 0:40:53)
Botanical and genomic research confirms that the Great Basin bristlecone pine (Pinus longaeva) exhibits extreme longevity, routinely living for thousands of years (with verified individual specimens exceeding 4,000 to 5,000 years in age), making it widely recognized as the longest-lived non-clonal tree species in the world.
Cultured whale cells do not lose their cellular identity rapidly even after sustaining DNA breaks.
"People study the cells of whales in the dish, and those cells don't lose their identity very quickly even when you break their DNA." (said at 0:41:45)
Published research on cultured bowhead whale cells (primary fibroblasts) shows that these cells possess exceptionally efficient and accurate DNA double-strand break repair mechanisms (driven by high expression of CIRBP and RPA2). Instead of undergoing rapid mutation, cellular degeneration, or aberrant transformation following DNA breaks, whale cells maintain genomic integrity and repair DNA breaks with uniquely high fidelity compared to other mammalian cells. Because this evidence is derived from in vitro cell culture experiments and comparative biology models, the GRADE certainty is very low.
Treating 16-month-old female mice with a chemical compound rejuvenates their ovaries and enables them to produce healthy offspring after reproductive cessation.
"We have published and repeated many times that if you treat old female mice 16 months of age, which is like a 65, 70-year-old human, that has long time since given up having offspring, we can treat the ovaries with a chemical that rejuvenates the eggs that are in the ovary, maybe even produces new ones, we don't know for sure, but those 16-month-old mice that stopped having kids probably at least 6 months ago, now start producing healthy offspring again." (said at 0:45:00)
The speaker accurately describes their published preclinical study in mice (Bertoldo et al., 2020, Cell Reports, PMID: 32049001). The authors demonstrated that oral administration of the NAD+ precursor nicotinamide mononucleotide (NMN) to reproductively aged mice restored NAD+ levels, rejuvenated oocyte quality, and improved ovulation and live birth rates after age-related fertility decline. Because the evidence is derived exclusively from rodent experiments and has not been established in humans, the GRADE certainty is rated as very low.
- supports: NAD + Repletion Rescues Female Fertility during Reproductive Aging. (Cell reports 2020) · cited 331x in the literature
"Treatment with the NAD + metabolic precursor nicotinamide mononucleotide (NMN) rejuvenates oocyte quality in aged animals, leading to restoration in fertility, and this can be recapitulated by transgenic overexpression of the NAD + -dependent deacylase SIRT2, though deletion of this enzyme does not impair oocyte quality. These benefits of NMN extend to the developing embryo, where supplementation reverses the adverse effect of maternal age on developmental milestones." (abstract, results, passage verified)
pubmedfull study (doi)
The phrase 'breakfast is the most important meal of the day' originated as marketing from breakfast cereal companies in the early 20th century.
"It turns out this idea breakfast is the most important meal of the day is marketing from the early 20th century by companies I will not name. But it was breakfast cereal." (said at 1:09:52)
Historical analysis of food marketing and American dietary culture shows that the modern concept and popularization of breakfast as the 'most important meal of the day' was heavily driven by breakfast cereal manufacturers and marketing campaigns in the early-to-mid 20th century (such as General Foods' 1944 Grape-Nuts campaign, as well as earlier marketing and advocacy by cereal pioneers such as John Harvey Kellogg and C.W. Post). Food industry marketing played a pivotal role in framing breakfast cereal consumption around health, productivity, and essential daily nutrition.
- context: Breakfast: The most important meal of the day? (International Journal of Gastronomy and Food Science 2017) · cited 107x in the literature
"In recent years, many of the larger food companies have become increasingly interested in trying either to break into the profitable, not to mention growing, market for breakfast foods, or else to figure out how to convince more consumers to eat ‘breakfast foods’ at other times of day." (abstract, passage verified)
openalexfull study (doi) - context: Sunny Side Up: The Storied Past of America's Most Important Meal of the Day (Texas ScholarWorks (Texas Digital Library) 2018)
"This thesis explores the role of breakfast as a reflection of American culture and history as it pertains to social perspectives of morality, war, gender, race, immigration, sexuality and popular media. This project critiques conventional explanations of political, economic and social history regarding the cultural manifestation of breakfast over the last 150 years in the United States." (abstract, passage verified)
openalexfull study (doi)
Yeast cells used in aging research live for about 10 days before dying.
"These yeast cells live about 10 days and then they die. And we used yeast as a model for aging." (said at 1:12:17)
Budding yeast (Saccharomyces cerevisiae) is a standard model organism in aging research. In chronological lifespan (CLS) assays—which measure how long non-dividing yeast cells remain viable in stationary phase—wild-type yeast typically survive for approximately 1 to 2 weeks (around 10 days) under standard culture conditions before viability declines.
David Sinclair and Leonard Guarente published a paper in Cell demonstrating the first evidence for a cause of aging in yeast.
"The first is Lenny and I, my professor and I published in the journal Cell, which was a massive big deal in those days, still is. It was my first time. The first evidence for a cause of aging for any species. We figured out why yeast cells get old." (said at 1:14:46)
In 1997, David Sinclair and Leonard Guarente published a study in Cell titled 'Extrachromosomal rDNA circles--a cause of aging in yeast' (PMID: 9428525), which demonstrated that the accumulation of extrachromosomal rDNA circles (ERCs) in yeast mother cells was a primary molecular cause of replicative aging in Saccharomyces cerevisiae. Because this finding is based on laboratory model-organism (yeast) experimentation, the GRADE certainty is very low.
- supports: Extrachromosomal rDNA circles--a cause of aging in yeast. (Cell 1997) · cited 1544x in the literature
"Although many cellular and organismal changes have been described in aging individuals, a precise, molecular cause of aging has yet to be found. A prior study of aging yeast mother cells showed a progressive enlargement and fragmentation of the nucleolus. Here we show that these nucleolar changes are likely due to the accumulation of extrachromosomal rDNA circles (ERCs) in old cells and that, in fact, ERCs cause aging." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Chromosomal breaks recruit sirtuins away from gene regulation to perform DNA repair, contributing to aging in yeast.
"So, we figured out that broken chromosomes distract the sirtuin defenses and that causes aging in a yeast cell." (said at 1:16:01)
The speaker's statement accurately summarizes the relational mechanism established in yeast: the silent information regulator (SIR/sirtuin) complex, which normally maintains transcriptional silencing at telomeres, rDNA, and mating-type loci, redistributes to DNA double-strand breaks to aid in repair. This diversion reduces silencing at its normal genomic sites, leading to phenotypic changes associated with yeast aging (such as loss of mating type sterility and rDNA instability). Because this evidence is derived from basic cell biology in model organisms, the GRADE certainty is rated very low.
- supports: MEC1-dependent redistribution of the Sir3 silencing protein from telomeres to DNA double-s… (Cell 1999) · cited 333x in the literature
"Here, we show that Sir3p is released from telomeres in response to DNA double-strand breaks (DSBs), binds to DSBs, and mediates their repair, independent of cell mating type." (abstract, results, passage verified)
pubmedfull study (doi) - supports: SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression du… (Cell 2008) · cited 847x in the literature
"The yeast histone deacetylase Sir2 silences transcription and stabilizes repetitive DNA, but during aging or in response to a DNA break, the Sir complex relocalizes to sites of genomic instability, resulting in the desilencing of genes that cause sterility, a characteristic of yeast aging." (abstract, results, passage verified)
pubmedfull study (doi)
Sirtuins require NAD as a cofactor/fuel to regulate gene expression and repair broken DNA.
"And what they found was that sirtuins, to control genes and to repair DNA that's broken, they don't do it unless there's NAD. It's the catalyst. It's the fuel for their reaction. They need NAD." (said at 1:18:20)
Sirtuins are a conserved family of class III lysine deacetylases and deacylases that strictly require nicotinamide adenine dinucleotide (NAD+) as a co-substrate to carry out their enzymatic activities, which include chromatin deacetylation to regulate gene expression and facilitating the repair of damaged DNA.
- supports: The Regulatory Role of NAD in Human and Animal Cells. (Biochemistry. Biokhimiia 2018) · cited 34x in the literature
"NAD+ also serves as a substrate for several families of regulatory proteins, such as protein deacetylases (sirtuins), ADP-ribosyltransferases, and poly(ADP-ribose) polymerases, that control vital cell processes including gene expression, DNA repair, apoptosis, mitochondrial biogenesis, unfolded protein response, and many others." (abstract, passage verified)
pubmedfull study (doi) - supports: Nicotinamide adenine dinucleotide (NAD+): essential redox metabolite, co-substrate and an … (Biochemical Society transactions 2020) · cited 56x in the literature
"In addition, many key enzymes that regulate diverse cell functions ranging from gene expression to proteostasis require NAD+ as a co-substrate for their catalytic activity. This includes the NAD+-dependent sirtuin family of protein deacetylases and the PARP family of DNA repair enzymes." (abstract, passage verified)
pubmedfull study (doi) - supports: Sirtuins as Therapeutic Targets for Treating Cancer, Metabolic Diseases, and Neurodegenera… (Pharmaceuticals (Basel, Switzerland) 2025) · cited 7x in the literature
"Sirtuins are NAD + -dependent enzymes that are conserved in all domains of life, including mammals, metazoans, plasmodia, yeast, bacteria, and archaea. In humans, there are seven isoforms (SIRT1 to 7), and they function in cellular homeostasis, aging, DNA repair, survival, metabolism, and stress responses." (abstract, passage verified)
pubmedfull study (doi)
Swallowing one gram of NMN typically doubles NAD levels in the human body.
"When you give a human NMN by swallowing it, a gram of it, you typically double the amount of NAD in your body." (said at 1:20:19)
Multiple randomized controlled trials in humans demonstrate that oral NMN supplementation at doses around 600 mg to 1,000 mg daily significantly increases circulating NAD+ levels, typically yielding an approximate doubling (roughly 1.5- to 2-fold increase) from baseline concentrations. While human trials specifically quantify NAD+ levels in whole blood, PBMCs, or serum rather than across every internal organ, the magnitude of NAD elevation at ~1 g/day closely matches the speaker's claim.
Animals do not produce polyphenols.
"So animals, unfortunately, don't make what are called polyphenols, which are a type of molecule that I believe and have evidence turns on the sirtuins and other pathways, biochemical reactions that delay aging." (said at 1:28:32)
Polyphenols (such as flavonoids, stilbenes like resveratrol, and phenolic acids) are secondary metabolites synthesized exclusively by plants, fungi, and certain microorganisms, primarily via the shikimate and phenylpropanoid pathways. Animals lack the biosynthetic machinery (such as the shikimate pathway and chalcone synthase) required to synthesize polyphenols de novo and must obtain them through their diet.
- supports: Resveratrol: from enhanced biosynthesis and bioavailability to multitargeting chronic dise… (Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2019) · cited 280x in the literature
"Resveratrol, a phytoalexin with a wide range of pharmacological properties is synthesised by plants in response to stress, injury, infection or UV radiations." (abstract, results, passage verified)
pubmedfull study (doi) - supports: A comprehensive review of six dietary polyphenols in colorectal cancer: Pharmacokinetics, … (Phytomedicine : international journal of phytotherapy and phytopharmacology 2025) · cited 1x in the literature
"Dietary polyphenols are secondary metabolites widely found in plant-derived foods and beverages, and have gained attention for their potential in CRC prevention and therapy due to their diverse biological activities." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Comprehensive review of biosynthesis, plant function, metabolism and new therapeutic bioac… (ADMET & DMPK 2026)
"Flavonoids are polyphenolic secondary metabolites synthesized via the phenylpropanoid pathway, serving as a vital biological "immune system" for plants by providing UV-B protection, antimicrobial defence, and pollinator attraction." (abstract, results, passage verified)
pubmedfull study (doi)
Polyphenols produced by plants under environmental stress, such as resveratrol, fisetin, and anthocyanidins, activate sirtuins in human cells.
"In their defense, they make polyphenols. There's a whole bunch of them. Resveratrol, fisetin, quercetin, there's hundreds. This one has anthocyanidins, that's the color. These activate these adversity responses in our cells. The sirtuins will get activated by molecules in this blueberry." (said at 1:29:49)
Plant polyphenols produced under environmental stress—including resveratrol, fisetin, quercetin, and anthocyanins—have been demonstrated in numerous in vitro cellular models and preclinical studies to modulate and activate sirtuins (most notably SIRT1). While substantial laboratory evidence demonstrates that these phytochemicals upregulate sirtuin signaling pathways (often via direct interaction or secondary signaling pathways such as AMPK), evidence is primarily mechanistic and derived from cell culture and animal models, with human bioavailability remaining a limiting factor in vivo.
- supports: SIRT1 Activation by Natural Phytochemicals: An Overview. (Frontiers in pharmacology 2020) · cited 307x in the literature
"This review will examine compounds of natural origin recently found to upregulate SIRT1 activity, such as polyphenolic products in fruits, vegetables, and plants including resveratrol, fisetin, quercetin, and curcumin." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Natural Phytochemicals as SIRT Activators-Focus on Potential Biochemical Mechanisms. (Nutrients 2023) · cited 101x in the literature
"Recent findings imply that phytochemicals such as resveratrol, curcumin, quercetin, fisetin, berberine, and kaempferol may regulate the activity of sirtuins. Resveratrol mainly activates SIRT1 and indirectly activates AMPK. Curcumin influences mainly SIRT1 and SIRT3, but its activity is broad, and many pathways in different cells are affected. Quercetin mainly modulates SIRT1, which triggers antioxidant and antiapoptotic responses. Fisetin, through SIRT1 regulation, modifies lipid metabolism and anti-inflammatory processes." (abstract, results, passage verified)
pubmedfull study (doi)
Between 15 and 24 hours of fasting, the human body produces a significant amount of ketone bodies for brain fuel.
"When you're between about 15 hours and 24 hours, that's when you get a lot of ketones. And your brain uses those for fuel" (said at 1:22:25)
Human metabolic physiology establishes that during short-term fasting (typically between 12-24 hours), liver glycogen stores are depleted, initiating the 'metabolic switch' to hepatic ketogenesis (beta-hydroxybutyrate and acetoacetate) derived from adipose tissue fatty acids. Circulating ketone bodies cross the blood-brain barrier and serve as an alternative energy substrate for the brain during fasting.
Periodic extended fasting that triggers preferential turnover of old proteins has been shown in animal studies to extend lifespan.
"ultimately, what happens after 3 days is your body says, "Hey, I'm going to start breaking down protein as well." And I wouldn't do that often because I don't want to break down a lot of protein, but your body will start to turn over old proteins preferentially. And a little bit of that, that's why I do it maybe once a month, has been shown, at least in animals, to be not just healthy, but life extending." (said at 1:22:44)
Animal studies support the claim that periodic extended fasting or fasting-mimicking diet (FMD) cycles promote cellular turnover/regeneration and extend lifespan in rodents. For example, bi-monthly FMD cycles initiated at middle age in mice significantly extended longevity, reduced tumor incidence, and promoted multi-system regeneration during post-fast re-feeding. Because the pro-longevity finding is established in model organisms and animal data inherently represent indirect evidence for humans, the GRADE certainty is very low.
- supports: A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive… (Cell metabolism 2015) · cited 880x in the literature
"Bi-monthly FMD cycles started at middle age extended longevity, lowered visceral fat, reduced cancer incidence and skin lesions, rejuvenated the immune system, and retarded bone mineral density loss." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Protein Quantity and Source, Fasting-Mimicking Diets, and Longevity. (Advances in nutrition (Bethesda, Md.) 2019) · cited 95x in the literature
"Protein restriction and FMDs together have the potential to play an important complementary role in medicine by promoting disease prevention and treatment, and by delaying the aging process at least in part by stimulating stem cell-based regeneration in periods of normal food intake after periodic FMD cycles." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Fasting mimicking diet extends lifespan and improves intestinal and cognitive health. (Food & function 2024) · cited 8x in the literature
"We found that FMD significantly prolonged the lifespan of prematurely aging mice. In naturally aging mice, FMD improved cognitive and intestinal health." (abstract, results, passage verified)
pubmedfull study (doi)
Polyphenols such as resveratrol and quercetin hyperactivate sirtuins, with NAD serving as the essential cofactor.
"The fuel for sirtuins is NAD. The accelerator pedal are the polyphenols in fruits and vegetables like resveratrol, quercetin, which we know when you give them to sirtuins, they get hyperactivated." (said at 1:30:40)
The biochemical mechanisms described by the speaker accurately reflect established molecular biology. Sirtuins are a conserved class of class III histone deacetylases whose catalytic deacetylation activity strictly requires nicotinamide adenine dinucleotide (NAD+) as an obligate cosubstrate/cofactor. Plant-derived polyphenols, notably resveratrol, quercetin, and fisetin, have been identified as sirtuin-activating compounds (STACs) that can stimulate or enhance SIRT1 enzymatic deacetylase activity in vitro and in cellular models.
- supports: Small Molecules as SIRT Modulators. (Mini reviews in medicinal chemistry 2018) · cited 91x in the literature
"Sirtuins are a family of NAD+-dependent deacetylases (class III histone deacetylases)... Some polyphenolic natural products such as Resveratrol, Fisetin, and Quercetin have demonstrated health benefits due to their SIRT1 activation effects." (abstract, results)
pubmedfull study (doi) - supports: SIRT1 Activation by Natural Phytochemicals: An Overview. (Frontiers in pharmacology 2020) · cited 307x in the literature
"Sirtuins are class III histone deacetylases, whose enzymatic activity is dependent on NAD + as a cofactor... This review will examine compounds of natural origin recently found to upregulate SIRT1 activity, such as polyphenolic products in fruits, vegetables, and plants including resveratrol, fisetin, quercetin, and curcumin." (abstract, results)
pubmedfull study (doi)
A UK Biobank MRI study found that consuming one glass of alcohol per day is associated with reduced brain size and gray matter volume.
"There's a UK Biobank study and the UK looked at thousands of people's MRI scan of their brain who were drinking one glass of alcohol a day and there was a statistical difference between people that were drinking one glass a day and were not in terms of brain size and gray matter. Of course, the gray matter was tended to be smaller in those that drank even slightly." (said at 1:32:35)
A large UK Biobank study of 36,678 middle-aged and older adults analyzed brain MRI scans and found statistically significant negative associations between alcohol intake and brain structure, including total brain volume and regional gray matter volumes. These reductions in brain volume and gray matter were detectable even at light-to-moderate consumption levels of 1 to 2 alcohol units per day (roughly equivalent to about half to one standard drink/glass per day). Because this is an observational cross-sectional imaging study, certainty is graded as low according to GRADE criteria.
The human brain does not take up cholesterol from the bloodstream, but synthesizes its own cholesterol locally.
"In fact, it's a little-known fact that the brain doesn't use the cholesterol from the bloodstream. It makes its own." (said at 1:35:54)
The speaker's assertion is fully supported by established physiological research. The blood-brain barrier is impermeable to circulating lipoprotein-bound cholesterol, preventing brain uptake of plasma cholesterol. Consequently, virtually all cholesterol present in the central nervous system is synthesized locally de novo (primarily by astrocytes and oligodendrocytes).
Sulforaphane activates the Nrf2 cellular stress response pathway.
"Sulforaphane is what it sounds. It has a sulfur atom in it. And that gives it that rotten egg smell. But sulforaphane activates these hormesis pathways. There's one called Nrf2, and that is a stress response protein that sulforaphane activates." (said at 1:40:40)
Sulforaphane (SFN) is a well-established electrophilic activator of the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway. Extensive biochemical, preclinical, and clinical research demonstrates that sulforaphane interacts with cysteine residues on Keap1 (the negative regulator of Nrf2), allowing Nrf2 to translocate to the nucleus and trigger the transcription of cytoprotective, antioxidant, and phase II detoxification genes via antioxidant response elements (ARE).
- supports: Broccoli for the brain: a review of the neuroprotective mechanisms of sulforaphane. (Frontiers in cellular neuroscience 2025) · cited 16x in the literature
"Through sulforaphane's ability to activate the mammalian Nuclear Factor Erythroid 2-related Factor 2 (NRF2) pathway, these beneficial properties extend beyond plants." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Sulforaphane as a potential therapeutic agent: a comprehensive analysis of clinical trials… (Journal of nutritional science 2025) · cited 18x in the literature
"SFN exerts its effects through well-characterised pathways, including the Keap1/Nrf2 axis, which regulates phase II detoxification enzymes, and epigenetic mechanisms such as histone deacetylase inhibition." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Sulforaphane in Cancer Prevention and Therapy: A State-of-the-Art Review of Epidemiologica… (International journal of molecular sciences 2026) · cited 5x in the literature
"SFN exerts multifaceted anticancer effects through the activation of the nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element (ARE) pathways, inhibition of histone deacetylases (HDACs) and hypoxia-inducible factor-1α (HIF-1α), and regulation of apoptosis and autophagy." (abstract, results, passage verified)
pubmedfull study (doi)
A CDC-funded study found that individuals who exercise regularly (jogging ~30 minutes 5 days a week) have telomeres that appear 10 years younger than sedentary individuals.
"On page 102 of your book, you talk about how there's a CDC-funded study that found people who exercise regularly, about 30 minutes of jogging 5 days a week, have telomeres that look 10 years younger than sedentary people, people that just sit around all day and don't do much exercise." (said at 1:45:14)
The host accurately describes a widely publicized cross-sectional study by Larry Tucker (2017) analyzing data from the CDC's National Health and Nutrition Examination Survey (NHANES 1999-2002) in 5,823 U.S. adults. The study found that individuals participating in high levels of physical activity (equivalent to approximately 30-40 minutes of jogging 5 days per week) had significantly longer leukocyte telomeres than sedentary individuals, translating to an estimated 9-year biological aging advantage (140 base pair difference divided by the 15.6 base pair loss observed per chronological year). Because the study is cross-sectional and observational, certainty is graded as low regarding causal effect.
Studies on Finnish men show that regular sauna bathing is associated with lower long-term mortality and reduced cardiovascular disease deaths.
"And in many studies, mostly on Finnish men, businessmen, uh those that go into their home saunas, and the majority of homes in Finland do have saunas, so they can do these studies pretty easily. The bottom line is that those that didn't do regular "sauna bathing" uh tended to die earlier, uh in particular from heart disease and cardiovascular events, than than those that did regular sauna bathing." (said at 1:47:29)
Large prospective cohort data from Finland directly support the claim. In the Kuopio Ischemic Heart Disease Risk Factor (KIHD) study of 2,315 middle-aged Finnish men followed for a median of 20.7 years (Laukkanen et al., 2015), increased frequency of sauna bathing was significantly associated with a dose-dependent reduction in all-cause mortality, sudden cardiac death, fatal coronary heart disease, and fatal cardiovascular disease. Because the evidence comes from prospective observational cohort studies rather than randomized controlled trials, certainty is graded as moderate.
Spermidine extends the lifespan of every animal model it has been tested in, ranging from worms to mice.
"Spermidine, the reason that I take it is that it extends the lifespan of every animal that has been given to, from worms to to mice. And it's a very safe molecule." (said at 1:51:51)
Preclinical studies consistently demonstrate that spermidine supplementation extends lifespan across all standard model organisms tested, including yeast (Saccharomyces cerevisiae), nematodes (Caenorhabditis elegans), fruit flies (Drosophila melanogaster), and rodents (mice). Because the evidence is derived exclusively from non-human model organisms, GRADE certainty is very low.
- supports: Induction of autophagy by spermidine promotes longevity. (Nature cell biology 2009) · cited 1680x in the literature
"Here, we report that administration of spermidine, a natural polyamine whose intracellular concentration declines during human ageing, markedly extended the lifespan of yeast, flies and worms, and human immune cells." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Cardioprotection and lifespan extension by the natural polyamine spermidine. (Nature medicine 2016) · cited 1149x in the literature
"Here we show that oral supplementation of the natural polyamine spermidine extends the lifespan of mice and exerts cardioprotective effects, reducing cardiac hypertrophy and preserving diastolic function in old mice." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Mechanisms of spermidine-induced autophagy and geroprotection. (Nature aging 2022) · cited 202x in the literature
"Among these geroprotectors, spermidine, a natural polyamine ubiquitously found in organisms from all kingdoms, prolongs the lifespan of fungi, nematodes, insects and rodents." (abstract, results, passage verified)
pubmedfull study (doi)
High-dose glycine supplementation extends the lifespan of laboratory mice.
"For some reason, when you give animals and, for instance, mice grams of glycine. So, I take about 5 g of glycine most days. Uh they live longer." (said at 1:52:34)
In a robust multi-site study conducted by the National Institute on Aging's Interventions Testing Program (ITP), an 8% glycine diet significantly extended both median lifespan (by 4% to 6%) and maximum lifespan in genetically heterogeneous male and female mice across three independent test sites (PMID 30916479). Because the evidence is exclusively from animal models, GRADE certainty is rated very low.
Niacin lowers circulating levels of Lipoprotein(a).
"And that's one of the few things that's been known to bring down levels of Lp(a). There are drugs that are in development, even in phase three, that look promising. But, until they're on the market, I'm taking niacin instead." (said at 1:57:14)
Extensive randomized placebo-controlled trial evidence confirms that niacin (nicotinic acid) significantly reduces circulating lipoprotein(a) [Lp(a)] concentrations. Meta-analyses of randomized trials demonstrate that extended-release niacin lowers Lp(a) levels by approximately 20% to 37%.
- supports: Effect of extended-release niacin on plasma lipoprotein(a) levels: A systematic review and… (Metabolism: clinical and experimental 2016) · cited 145x in the literature
"Meta-analysis suggested a significant reduction of Lp(a) levels following ER niacin treatment (weighted mean difference - WMD: -22.90%, 95% CI: -27.32, -18.48, p<0.001)." (abstract, results)
pubmedfull study (doi) - supports: Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis… (Atherosclerosis 2025) · cited 26x in the literature
"Lp(a) levels were significantly reduced by PCSK9 monoclonal antibodies (PCSK9mAbs, -6.37 mg/dL [-7.26 to -5.47], a 29% reduction from baseline), inclisiran (-4.76 mg/dL [-5.83 to -3.69], a 22% reduction from baseline), CETP inhibitors (CETPi, -6.77 mg/dL [-8.67 to -4.88], a 46% reduction from baseline), and niacin (-7.06 mg/dL [-9.27 to -4.85], a 37% reduction from baseline)." (abstract, results)
pubmedfull study (doi)
Testosterone replacement therapy does not increase the risk of cancer.
"There is not a big downside, there's not a risk of cancer to taking testosterone. Um one of my good friends has done many clinical trials with testosterone." (said at 1:59:46)
Systematic reviews and meta-analyses of randomized controlled trials (RCTs) evaluating testosterone replacement therapy (TRT) in hypogonadal men consistently find no statistically significant increase in the risk of prostate cancer or other malignancies compared to placebo. While long-term multi-decade data remain an ongoing area of study, the best available randomized trial evidence supports the conclusion that TRT does not increase cancer risk.
Omega-9 fatty acids activate sirtuin enzymes.
"There's omega-9, which is also known to activate sirtuins." (said at 1:38:52)
Preclinical in vitro and animal studies demonstrate that monounsaturated omega-9 fatty acids, predominantly oleic acid, activate sirtuin 1 (SIRT1). Mechanistic work shows oleic acid directly and allosterically activates SIRT1 toward specific substrates (such as PGC-1α) and enhances SIRT1 catalytic deacetylase activity via cAMP/PKA phosphorylation signaling. Because evidence is currently derived from cell culture and animal models, certainty is graded as very low.
Resveratrol supplementation in mice fed a high-fat diet extended their lifespan by approximately 15 to 20 percent.
"And we fed it to mice, fat mice, skinny mice, old mice, and it worked very well in the fat mice. It made them thinner. It made them live longer. It cured most of their diseases. They lived about I think it was 15 20% longer." (said at 1:41:12)
In a landmark 2006 study by Baur, Sinclair, and colleagues (PMID: 17086191), resveratrol supplementation in middle-aged mice fed a high-calorie diet significantly improved health parameters and increased survival compared to high-calorie controls (bringing their lifespan closer to standard-diet controls, an increase of roughly 15-20%). Because evidence is derived entirely from animal models, the GRADE certainty is rated very low.
- supports: Resveratrol improves health and survival of mice on a high-calorie diet. (Nature 2006) · cited 4257x in the literature
"Here we show that resveratrol shifts the physiology of middle-aged mice on a high-calorie diet towards that of mice on a standard diet and significantly increases their survival. Resveratrol produces changes associated with longer lifespan, including increased insulin sensitivity, reduced insulin-like growth factor-1 (IGF-I) levels, increased AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) activity, increased mitochondrial number, and improved motor function." (abstract, results, passage verified)
pubmedfull study (doi)
Berberine activates the AMP-activated protein kinase (AMPK) pathway.
"If I take metformin or the natural equivalent, which is berberine, if you don't want to take the drug, you can take berberine, um that also activates this AMPK, this sirtuin-like pathway." (said at 1:42:44)
Extensive mechanistic and preclinical evidence confirms that berberine activates the AMP-activated protein kinase (AMPK) signaling pathway (including the downstream AMPK/SIRT1 axis), mimicking key metabolic mechanisms of metformin.
- supports: Mitochondrial Health Through Nicotinamide Riboside and Berberine: Shared Pathways and Ther… (International journal of molecular sciences 2026) · cited 11x in the literature
"BBR, by contrast, primarily activates AMPK (AMP-activated protein kinase) and interacts with respiratory complex I, improving bioenergetics, reducing mitochondrial reactive oxygen species, and promoting mitophagy and organelle quality control." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Berberine Regulates Hepatic Fatty Acid Metabolism via AMPK/SIRT1/PGC-1α Pathway. (Chinese journal of integrative medicine 2026) · cited 1x in the literature
"Berberine activates AMPK/SIRT1/PGC-1α pathway, thereby improving fatty acid metabolism, and ultimately exerts therapeutic effects on NAFLD accompanied by T2DM." (abstract, conclusions)
pubmedfull study (doi) - supports: Natural Bioactive Compounds Targeting Key Hallmarks of Aging: Functional Food Potential of… (Nutrients 2026)
"Berberine, an isoquinoline alkaloid from Berberis species, modulates metabolic dysfunction via AMP-activated protein kinase (AMPK) activation and reshapes gut microbiota composition through direct high intraluminal exposure, with the most extensive clinical dataset of the four compounds." (abstract, results, passage verified)
pubmedfull study (doi)
Dihydrotestosterone (DHT) is the active metabolite of testosterone that causes male-pattern hair loss.
"I'm taking a hormone mimetic to stop uh DHT, which is the form of testosterone that leads to men-related hair loss." (said at 1:58:46)
The claim is fully supported by established endocrinological and dermatological evidence. Dihydrotestosterone (DHT) is synthesized from testosterone by 5-alpha reductase isoenzymes and is the primary pathogenic androgen responsible for androgenetic alopecia (male-pattern hair loss) via the miniaturization of genetically susceptible scalp hair follicles.
- supports: 5-Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concept… (Dermatologic therapy 2020) · cited 77x in the literature
"Dihydrotestosterone, the main pathogenic androgen in AGA, is produced by conversion of testosterone, which is catalyzed by the 5-alpha reductase (5-AR) isoenzyme family." (abstract, passage verified)
pubmedfull study (doi) - supports: Advances in the treatment of male androgenetic alopecia: current options and emerging ther… (Italian journal of dermatology and venereology 2025)
"Androgenetic alopecia (AGA), or pattern hair loss, is the most common form of hair loss worldwide. It is primarily caused by genetic and hormonal factors, particularly the action of dihydrotestosterone (DHT) on hair follicles." (abstract, background, passage verified)
pubmedfull study (doi)
Doxycycline is an antibiotic medication used to treat malaria and Lyme disease.
"How? We give them doxycycline. It's used for malaria, it's used for Lyme disease, and we're using it in this case to turn these genes on." (said at 2:06:24)
Doxycycline is a broad-spectrum tetracycline antibiotic that is well-established and FDA-approved as a primary first-line treatment for Lyme disease (Borrelia burgdorferi infection) as well as for the prevention (prophylaxis) and treatment (in combination regimens, e.g., with quinine or artesunate) of malaria.
Individuals who have a sense of purpose live longer.
"We all need to find purpose, for sure. If you don't find one, cuz that's a key to longevity. People with purpose live longer." (said at 2:21:47)
Large-scale prospective cohort studies and meta-analyses robustly demonstrate that having a higher sense of purpose in life is associated with significantly reduced all-cause mortality and increased longevity. A comprehensive meta-analysis and individual-participant data analysis of 488,765 individuals followed for up to 32 years found that a sense of purpose in life was associated with an approximate 24-30% lower risk of all-cause mortality (HR = 0.76, 95% CI: 0.70-0.83). This association remained significant after adjusting for sociodemographic factors, depression, and behavioral or clinical risk factors.
- supports: Purpose in life and mortality: A meta-analysis of the published literature and individual-… (Psychological medicine 2026)
"Purpose in life was associated with a ~ 30% lower risk of earlier mortality (meta-analytic HR = .76 [1/.76 = 1.32], 95% CI = .70, .83). The association was apparent across sociodemographic groups, with some small differences in magnitude by age, race, and education. The association was attenuated but persisted, controlling for behavioral and clinical risk factors for mortality (meta-analytic HR = .85, 95% CI = .82, .89), or depression (meta-analytic HR = .91, 95% CI = .88, .94)." (abstract, results)
pubmedfull study (doi)
Adeno-associated virus serotype 2 (AAV2) is used as a gene delivery vehicle to target nerve cells at the back of the retina.
"these little balls on the on the package direct it specifically, by design, by our lab's design, just to those nerves at the back of the eye. If we change these little proteins on the surface, we can send it to the liver or to the brain... But this one's designed for the eye. It's called an AAV2." (said at 2:03:51)
The claim is supported. Adeno-associated virus serotype 2 (AAV2) is the standard and widely utilized viral vector for targeting retinal ganglion cells (the nerve cells located at the inner surface / back of the retina) via intravitreal injection in retinal gene therapy. Capsid surface proteins mediate vector tropism, determining the specific tissue and cell types transduced.
Doxycycline is used in genetic engineering systems to act as an inducible chemical switch to activate target genes.
"We've engineered it uniquely and patented the ability to turn on those three genes whenever we want and turn them off again whenever we want. How? We give them doxycycline. It's used for malaria, it's used for Lyme disease, and we're using it in this case to turn these genes on." (said at 2:06:24)
The claim is supported. Doxycycline is a widely established small-molecule inducer used in molecular biology and genetic engineering (specifically the Tet-On system) to activate or regulate the expression of target genes reversibly. In the Tet-On system, the presence of doxycycline binds the reverse tetracycline-controlled transactivator (rtTA) protein, triggering transcription of downstream genes placed under tetracycline-responsive promoters. Doxycycline is also well established clinically as an antibiotic for conditions such as Lyme disease and malaria prophylaxis.
In the double-slit experiment, measuring or detecting which slit a particle passes through collapses its wave function, causing it to form two bands instead of a wave interference pattern.
"Electrons, if you're observing them, will go straight through the slits and hit a backboard that detects it. Can be film, can be a detector. And it'll get two slits behind... If you don't look at it, the particles can behave differently. They now behave not like a particle, but as a wave and they interact with each other and they don't make two slits, they make multiple lines on the detector." (said at 1:56:40)
The speaker describes the foundational quantum-mechanical double-slit experiment and the observer effect / which-way detection. When particles (such as electrons or photons) pass through a double-slit unobserved, they exhibit wave-like behavior, producing an interference pattern (multiple fringes/lines) on the detector screen. When a measurement or detector determines which slit each particle passes through, phase coherence is destroyed (or the wave function collapses), eliminating the interference fringes and yielding a distribution corresponding to the two separate slits.
The molecular building blocks of DNA and proteins, such as nucleobases and amino acids, have been detected on meteorites.
"and that the stuff of DNA and proteins are all over meteorites and planets. It'd be crazy to say there isn't other life." (said at 2:00:48)
Spectroscopic and chromatographic analyses of carbonaceous meteorites have definitively established the presence of extraterrestrial amino acids (the monomers of proteins) and purine and pyrimidine nucleobases (the structural units of DNA and RNA). Recent high-sensitivity analytical studies have confirmed the detection of all canonical nucleobases found in DNA and RNA (adenine, guanine, cytosine, uracil, and thymine) as well as dozens of proteinaceous and non-proteinaceous amino acids in meteorites such as Murchison.
- supports: A new family of extraterrestrial amino acids in the Murchison meteorite (Scientific Reports 2017) · cited 169x in the literature
"In particular, amino acids have been studied in carbonaceous meteorites for almost 50 years. Here we report ten new amino acids identified in the Murchison meteorite, including a new family of nine hydroxy amino acids." (abstract, passage verified)
openalexfull study (doi) - supports: Identifying the wide diversity of extraterrestrial purine and pyrimidine nucleobases in ca… (Nature Communications 2022) · cited 161x in the literature
"In addition to previously detected purine nucleobases in meteorites such as guanine and adenine, we identify various pyrimidine nucleobases such as cytosine, uracil, and thymine, and their structural isomers such as isocytosine, imidazole-4-carboxylic acid, and 6-methyluracil, respectively." (abstract, passage verified)
openalexfull study (doi)
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.